pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,688 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT821Endpoints617BioPharma Dive237onclive165BioSpace86Fierce Biotech85raps32globenewswire health26fda press
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology
  • Trump’s cuts to foreign aid are undermining the Ebola response, insiders say
    President Trump's cuts to foreign aid probably hampered the detection of the Ebola outbreak and the response to it.
    STAT · 2mo ago↗ source
  • STAT+: Virginia governor vetoes legislation to create an advisory panel to lower the cost of prescription drugs
    Virginia's governor vetoed a closely watched effort to create an advisory panel to lower prescription drug costs.
    STAT · 2mo ago↗ source
  • STAT+: This spine surgery usually costs $1,400. Under No Surprises Act arbitration? $34,000
    A new analysis shows how some clinicians are cashing in on a new process designed to protect patients from surprise bills.
    STAT · 2mo ago↗ source
← prev
page 42 of 68
next →
21
fda recalls20
fda medwatch16
6
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
  • How AI helped treat a newborn’s ultra rare disease. ‘It was almost like a light switch.’
    The parents of Jorie Kraus told the audience at STAT's Breakthrough Summit West about how AI helped their daughter who was born with a rare disease.
    STAT · 2mo ago↗ source
  • TrumpRx adds hundreds of generic medicines to site
    The Trump administration is significantly building the portfolio of drugs available through its direct-to-consumer platform TrumpRx, adding more than 600 generic medicines. President Donald Trump o…
    Endpoints · 2mo ago↗ source
  • Another Paragon offshoot chooses reverse merger, this time for migraine drugs
    They say stick to what you know. And Paragon Therapeutics knows how to do reverse mergers. The hub-and-spoke biologics company is moving its migraine drug offshoot, Mentari Therapeutics, onto the p…
    Endpoints · 2mo ago↗ source
  • Acceleron leaders and Westlake jumpstart new IPF biotech
    After success with the drug Winrevair, a band of entrepreneurs has found their next challenge in a difficult-to-treat lung disease. On Tuesday, Oorja Bio launched with a $30 million Series A round,…
    Endpoints · 2mo ago↗ source
  • STAT+: Canadian medical societies lack sufficient conflict-of-interest policies, study finds
    Most Canadian medical societies lack comprehensive policies governing conflicts of interest, and many policies are generally fragmented and narrow in scope, according to a new analysis.
    STAT · 2mo ago↗ source
  • STAT+: At a time of tumult at FDA, a former commissioner is hopeful it’s on a better path
    With the FDA facing upheaval and personnel exits, former commissioner David Kessler sees an opportunity whereby the agency can make a turn for the better.
    STAT · 2mo ago↗ source
  • STAT+: TrumpRx adds generic drugs
    A deal with Mark Cuban, Amazon Pharmacy, and GoodRx is boosting TrumpRx's offerings.
    STAT · 2mo ago↗ source
  • The state of consumer health
    On Thursday, the Health Tech team led a series of conversations at the Financial Times’ US Pharma and Biotech Summit, held in collaboration with Endpoints News. The sessions focused on ...
    Endpoints · 2mo ago↗ source
  • Q&A: Novo research chief Petersen says streamlined R&D speeds discovery
    Just as Maziar Mike Doustdar took the helm at Novo Nordisk in the summer of 2025, the company said it would reorganize its R&D activities, merging the teams that focused on early ...
    Endpoints · 2mo ago↗ source
  • Wave aims for monthly dosing with RNA editing treatment for AATD
    Wave Life Sciences reported an updated cut of data from its early-stage study of an RNA editing treatment for alpha-1 antitrypsin deficiency, suggesting it can dose its genetic therapy monthly. Peo…
    Endpoints · 2mo ago↗ source
  • Full-Life Technologies raises $150M; Quince's reboot with pulmonary drug
    Plus, news about Accro Bioscience, Hansa Biopharma, Shanghai Best-Link Bioscience and UCB. Full-Life Technologies gets $150M: The radiotherapy company has raised $110 million in a Series D round an…
    Endpoints · 2mo ago↗ source
  • STAT+: Dexcom CEO hints at future uses for CGM
    In this edition of STAT Health Tech: Takeaways from a conversation with Dexcom CEO, and updates on WiSeR, and Epic's market share.
    STAT · 2mo ago↗ source
  • STAT+: A new ranking of pharma companies by R&D performance
    Maryland drug board to cap price of Ozempic, TrumpRx partners with Cuban, GoodRx, and more biotech news
    STAT · 2mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much more
    The latest pharmaceutical news from the Pharmalot campus via the Pharmalittle newsletter
    STAT · 2mo ago↗ source
  • Nourish raises $100M for virtual nutrition care
    Nourish, a telehealth platform that arranges virtual appointments with nutritionists, just raised a new round that bumped its valuation to $1.75 billion, according to a person familiar with the mat…
    Endpoints · 2mo ago↗ source
  • STAT+: Eli Lilly tops prominent rankings on pharma R&D performance
    A new set of lists ranks drug company laboratories on two criteria: innovation and invention.
    STAT · 2mo ago↗ source
  • The latest on Ebola: A travel ban and an old vaccine
    Affordable Care Act changes, drinking while pregnant, and more health news from Morning Rounds
    STAT · 2mo ago↗ source
  • Relay's PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies study
    Relay Therapeutics’ first data readout for zovegalisib in a rare genetic disease beat Wall Street expectations, expanding the PI3Kα inhibitor’s R&D prospects beyond breast cancer. The biotech on Tu…
    Endpoints · 2mo ago↗ source
  • BioMarin's rare disease therapy shows no clinical benefit in Phase 3 test
    BioMarin’s enzyme replacement therapy for a rare genetic disorder called ENPP1 deficiency delivered mixed results in a late-stage study. Patients with the condition don't produce enough of the ENPP…
    Endpoints · 2mo ago↗ source
  • STAT+: 1 in 8 women drink during pregnancy. Experts dread the consequences
    More than 1 in 8 pregnant women report drinking. Doctors warn fetal alcohol disorders may be more common than many realize, perhaps more common than autism.
    STAT · 2mo ago↗ source
  • Opinion: Britain embraces a Massachusetts experiment on tobacco regulation — just as the state might roll it back
    Britain embraces a Massachusetts experiment on tobacco regulation — just as the commonwealth might roll it back.
    STAT · 2mo ago↗ source
  • Opinion: I’m a heart transplant recipient. I’m haunted by ‘ghost approval’ for medication I need to survive
    “On paper, I have insurance coverage. In real life, I don’t have access. That’s what I call ‘ghost approval,’” writes patient advocate Payton Herres.
    STAT · 2mo ago↗ source